WBA Stock Cash Flow Statements

Walgreens Boots Alliance Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Walgreens Boots Alliance Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-05-31	2025-02-28	2024-11-30	2024-08-31	2024-05-31	2024-02-29	2023-11-30	2023-08-31	2023-05-31	2023-02-28	2022-11-30	2022-08-31	2022-05-31	2022-02-28	2021-11-30	2021-08-31	2021-05-31	2021-02-28	2020-11-30	2020-08-31	2020-05-31	2020-02-29	2019-11-30	2019-08-31	2019-05-31	2019-02-28	2018-11-30	2018-08-31	2018-05-31	2018-02-28	2017-11-30	2017-08-31	2017-05-31	2017-02-28	2016-11-30	2016-05-31	2015-08-31	2015-05-31	2015-02-28	2014-11-30

cash flows from operating activities:
net income	-196,000,000	-4,035,000,000	-605,000,000		230,000,000	-12,322,000,000	-278,000,000																																	-14,000,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	573,000,000	611,000,000	625,000,000	622,000,000	607,000,000	614,000,000	616,000,000	605,000,000	597,000,000	560,000,000	495,000,000	488,000,000	478,000,000	524,000,000	500,000,000	518,000,000	507,000,000	473,000,000	475,000,000	480,000,000	478,000,000	492,000,000	477,000,000	526,000,000	522,000,000	500,000,000	490,000,000	470,000,000	442,000,000	442,000,000	416,000,000	410,000,000	413,000,000	412,000,000	419,000,000	447,000,000	478,000,000	438,000,000
deferred income taxes	75,000,000	-31,000,000	-23,000,000	2,159,000,000	89,000,000	-1,135,000,000	-196,000,000	-273,000,000	-498,000,000	2,000,000	-1,602,000,000	-198,000,000	-262,000,000	-70,000,000	164,000,000	443,000,000	54,000,000	84,000,000	-348,000,000	59,000,000	-57,000,000	17,000,000	-62,000,000	-9,000,000	-52,000,000	137,000,000	24,000,000	60,000,000	92,000,000	-411,000,000	-63,000,000	-223,000,000	15,000,000	-165,000,000	-61,000,000	-79,000,000	-272,000,000	59,000,000
stock compensation expense	41,000,000	21,000,000	38,000,000	39,000,000	44,000,000	48,000,000	51,000,000	37,000,000	55,000,000	71,000,000	222,000,000	125,000,000	96,000,000	135,000,000	35,000,000	35,000,000	50,000,000	34,000,000	36,000,000	36,000,000	34,000,000	39,000,000	28,000,000	32,000,000	24,000,000	36,000,000	27,000,000	39,000,000	28,000,000	38,000,000	25,000,000	20,000,000	19,000,000	26,000,000	26,000,000	27,000,000	23,000,000	21,000,000
earnings from equity method investments	-45,000,000			-51,000,000	-42,000,000	-89,000,000	-48,000,000		-63,000,000	-82,000,000	-61,000,000
impairment of goodwill, intangibles and long-lived assets	116,000,000			752,000,000	29,000,000
gain on sale of equity method investments	0	-359,000,000	-32,000,000	-673,000,000	-89,000,000	-619,000,000	-139,000,000	-164,000,000	-179,000,000	-543,000,000	-969,000,000	-138,000,000
gain on sale-leaseback transactions				-27,000,000	-10,000,000	-98,000,000	-160,000,000	-100,000,000
(gain) loss on variable prepaid forward contracts	11,000,000
other	-44,000,000	-92,000,000	13,000,000	-91,000,000	-30,000,000	-156,000,000	35,000,000	-426,000,000	652,000,000	-254,000,000	-129,000,000	53,000,000	-139,000,000	-155,000,000	95,000,000	77,000,000	-37,000,000	-33,000,000	-71,000,000	159,000,000	268,000,000	9,000,000	28,000,000	260,000,000	-113,000,000	58,000,000	97,000,000	30,000,000	179,000,000	-65,000,000	152,000,000	75,000,000	105,000,000	103,000,000	81,000,000	-210,000,000	-10,000,000	348,000,000
changes in certain assets and liabilities:
accounts receivable	-523,000,000	226,000,000	-414,000,000	128,000,000	258,000,000	-232,000,000	-618,000,000	483,000,000	-190,000,000	-372,000,000	151,000,000	83,000,000	230,000,000	622,000,000	-127,000,000	-554,000,000	-341,000,000	-297,000,000	-259,000,000	22,000,000	465,000,000	-208,000,000	-116,000,000	-59,000,000	434,000,000	-649,000,000	-515,000,000	371,000,000	-125,000,000	-275,000,000	-362,000,000	0	-342,000,000	448,000,000	-259,000,000	160,000,000	-65,000,000	118,000,000
inventories	663,000,000	1,271,000,000	-904,000,000	284,000,000	-36,000,000	901,000,000	-1,180,000,000	-39,000,000	563,000,000	681,000,000	-918,000,000	77,000,000	293,000,000	549,000,000	-1,352,000,000	94,000,000	319,000,000	977,000,000	-1,225,000,000	290,000,000	15,000,000	857,000,000	-1,099,000,000	495,000,000	203,000,000	867,000,000	-1,424,000,000	101,000,000	544,000,000	704,000,000	-1,018,000,000	-161,000,000	766,000,000	823,000,000	-1,330,000,000	72,000,000	40,000,000	573,000,000
other current assets	9,000,000	10,000,000	36,000,000	24,000,000	5,000,000	95,000,000	-42,000,000	-4,000,000	-77,000,000	-39,000,000	-68,000,000	-14,000,000	-21,000,000	21,000,000	-58,000,000	-64,000,000	27,000,000	-45,000,000	36,000,000	-90,000,000	3,000,000	61,000,000	-5,000,000	-32,000,000	-19,000,000	22,000,000	-83,000,000	-18,000,000	62,000,000	88,000,000	-154,000,000		5,000,000	126,000,000	-109,000,000	-12,000,000	-32,000,000	33,000,000
trade accounts payable	151,000,000	-1,190,000,000	563,000,000	963,000,000	304,000,000	-824,000,000	966,000,000	616,000,000	-652,000,000	412,000,000	867,000,000	-523,000,000	721,000,000	-1,289,000,000	1,335,000,000	-85,000,000	184,000,000	-655,000,000	1,398,000,000	185,000,000	-765,000,000	-369,000,000	924,000,000	292,000,000	-20,000,000	-415,000,000	1,097,000,000	696,000,000	35,000,000	-419,000,000	1,011,000,000	869,000,000	32,000,000	-95,000,000	884,000,000	526,000,000	249,000,000	-344,000,000
accrued expenses and other liabilities	25,000,000	-217,000,000	37,000,000	-62,000,000	-494,000,000	-185,000,000	205,000,000	27,000,000	96,000,000	-415,000,000	-269,000,000	224,000,000	114,000,000	-77,000,000	-399,000,000	618,000,000	174,000,000	359,000,000	-105,000,000	439,000,000	430,000,000	94,000,000	45,000,000	268,000,000	-100,000,000	-201,000,000	-341,000,000	271,000,000	-172,000,000	404,000,000	-222,000,000	140,000,000	41,000,000	69,000,000	-378,000,000	-168,000,000	322,000,000	-132,000,000	-34,000,000	14,000,000
income taxes	93,000,000	-390,000,000	93,000,000	-137,000,000	-89,000,000	160,000,000	96,000,000	225,000,000	124,000,000	-61,000,000	153,000,000	-133,000,000	-72,000,000	75,000,000	79,000,000	106,000,000	107,000,000	-185,000,000	132,000,000	132,000,000	2,000,000	-357,000,000	2,000,000	-34,000,000	150,000,000	-616,000,000	94,000,000	-99,000,000	-110,000,000	657,000,000	246,000,000	38,000,000	-148,000,000	-63,000,000	217,000,000	43,000,000	-156,000,000	-80,000,000
accrued litigation obligations	-219,000,000	-215,000,000	-20,000,000	-3,000,000	61,000,000	-337,000,000	-54,000,000	-457,000,000	40,000,000	301,000,000	6,494,000,000
other non-current assets and liabilities	-143,000,000	-173,000,000	-39,000,000	-95,000,000	-77,000,000	-404,000,000	-67,000,000	-49,000,000	-54,000,000	-67,000,000	-58,000,000	-183,000,000	467,000,000	-111,000,000	-36,000,000	-168,000,000	-108,000,000	-86,000,000	74,000,000	86,000,000	17,000,000	-120,000,000	1,000,000	17,000,000	-67,000,000	-50,000,000	-54,000,000	-158,000,000	-45,000,000	-81,000,000	9,000,000	54,000,000	-153,000,000	169,000,000	-3,000,000	-50,000,000	105,000,000	-22,000,000
net cash from operating activities	584,000,000	-199,000,000	-140,000,000	1,332,000,000	604,000,000	-637,000,000	-281,000,000	1,039,000,000	-20,000,000	746,000,000	493,000,000	86,000,000	1,629,000,000	1,085,000,000	1,099,000,000	1,245,000,000	1,754,000,000	1,361,000,000	1,195,000,000	2,086,000,000	914,000,000	1,423,000,000	1,061,000,000	2,379,000,000	2,020,000,000	735,000,000	460,000,000	2,880,000,000	2,209,000,000	2,215,000,000	961,000,000	2,014,000,000	1,855,000,000	2,857,000,000	525,000,000	2,104,000,000	1,505,000,000	1,822,000,000
capex	-248,000,000	-219,000,000	-284,000,000	-246,000,000	-277,000,000	-352,000,000	-506,000,000	-484,000,000	-525,000,000	-498,000,000	-610,000,000	-493,000,000	-371,000,000	-416,000,000	-454,000,000	-378,000,000	-309,000,000	-261,000,000	-431,000,000	-412,000,000	-257,000,000	-318,000,000	-387,000,000	-456,000,000	-453,000,000	-323,000,000	-470,000,000	-384,000,000	-317,000,000	-288,000,000	-378,000,000	-439,000,000	-273,000,000	-261,000,000	-378,000,000	-247,000,000	-361,000,000	-247,000,000
free cash flows	336,000,000	-418,000,000	-424,000,000	1,086,000,000	327,000,000	-989,000,000	-787,000,000	555,000,000	-545,000,000	248,000,000	-117,000,000	-407,000,000	1,258,000,000	669,000,000	645,000,000	867,000,000	1,445,000,000	1,100,000,000	764,000,000	1,674,000,000	657,000,000	1,105,000,000	674,000,000	1,923,000,000	1,567,000,000	412,000,000	-10,000,000	2,496,000,000	1,892,000,000	1,927,000,000	583,000,000	1,575,000,000	1,582,000,000	2,596,000,000	147,000,000	1,857,000,000	1,144,000,000	1,575,000,000
cash flows from investing activities:
additions to property, plant and equipment	-248,000,000	-219,000,000	-284,000,000	-246,000,000	-277,000,000	-352,000,000	-506,000,000	-484,000,000	-525,000,000	-498,000,000	-610,000,000	-493,000,000	-371,000,000	-416,000,000	-454,000,000	-378,000,000	-309,000,000	-261,000,000	-431,000,000	-412,000,000	-257,000,000	-318,000,000	-387,000,000	-456,000,000	-453,000,000	-323,000,000	-470,000,000	-384,000,000	-317,000,000	-288,000,000	-378,000,000	-439,000,000	-273,000,000	-261,000,000	-378,000,000	-247,000,000	-361,000,000	-247,000,000
proceeds from sale-leaseback transactions	0			125,000,000	46,000,000	300,000,000	427,000,000	218,000,000	607,000,000	533,000,000	409,000,000	499,000,000	334,000,000	273,000,000	202,000,000	194,000,000	210,000,000	221,000,000	231,000,000		224,000,000	186,000,000	147,000,000
proceeds from sale of other assets	282,000,000	605,000,000	164,000,000	1,134,000,000	415,000,000	1,007,000,000	304,000,000	697,000,000	537,000,000	1,193,000,000	2,068,000,000	358,000,000	943,000,000			47,000,000	137,000,000	240,000,000	29,000,000	38,000,000	15,000,000	15,000,000	22,000,000	22,000,000	41,000,000	24,000,000	30,000,000	434,000,000	203,000,000	5,000,000	13,000,000	20,000,000	17,000,000	-4,000,000	26,000,000	31,000,000	113,000,000
business, investment and asset acquisitions, net of cash acquired	-11,000,000	-7,000,000	-18,000,000	-196,000,000	22,000,000	-119,000,000	-109,000,000	-241,000,000	-259,000,000	-6,733,000,000	-80,000,000	-149,000,000	-122,000,000	-118,000,000	-1,800,000,000	-37,000,000	-80,000,000	-1,237,000,000	-77,000,000	-373,000,000	-59,000,000	-106,000,000	-180,000,000	-274,000,000	-120,000,000	-147,000,000	-200,000,000
net cash from investing activities	-82,000,000	418,000,000	-76,000,000	772,000,000	204,000,000	817,000,000	85,000,000	155,000,000	334,000,000	-5,441,000,000	1,858,000,000	198,000,000	919,000,000			5,413,000,000	15,000,000	-1,097,000,000	-259,000,000	-637,000,000	-43,000,000	-215,000,000	-402,000,000	-738,000,000	-523,000,000	-411,000,000	-635,000,000	-390,000,000	-955,000,000	-3,557,000,000	-599,000,000	-391,000,000	-255,000,000			-1,409,000,000	-392,000,000	824,000,000
cash flows from financing activities:
net change in short-term debt with maturities of 3 months or less			12,000,000	-1,000,000	-427,000,000	271,000,000	155,000,000	-148,000,000	-981,000,000	1,106,000,000	22,000,000	-1,000,000	-1,299,000,000	352,000,000	937,000,000	-2,465,000,000	1,206,000,000	697,000,000	-347,000,000	-357,000,000	851,000,000	-263,000,000	-392,000,000	237,000,000	-37,000,000	-731,000,000	1,067,000,000	-10,000,000	-240,000,000
proceeds from debt	10,413,000,000	11,339,000,000	3,229,000,000	8,291,000,000	8,073,000,000	11,175,000,000	3,826,000,000	1,036,000,000	3,524,000,000	1,699,000,000	17,000,000	14,000,000	2,016,000,000	1,988,000,000	7,940,000,000	6,000,000	6,182,000,000	3,228,000,000	3,310,000,000	4,031,000,000	6,476,000,000	4,788,000,000	5,072,000,000	2,142,000,000	3,877,000,000	5,329,000,000	1,085,000,000	857,000,000	1,954,000,000
payments of debt	-11,151,000,000	-11,367,000,000	-4,679,000,000	-7,346,000,000	-8,180,000,000	-11,172,000,000	-3,776,000,000	-3,746,000,000	-3,702,000,000	-1,519,000,000	-11,000,000	-1,010,000,000	-19,000,000	-2,887,000,000	-4,444,000,000	-4,207,000,000	-4,547,000,000	-3,696,000,000	-2,807,000,000	-4,543,000,000	-7,406,000,000	-4,763,000,000	-4,702,000,000	-3,129,000,000	-4,215,000,000	-2,572,000,000	-545,000,000	-1,383,000,000	-2,228,000,000	-1,187,000,000	-92,000,000
proceeds from variable prepaid forward contracts					0	0	424,000,000
treasury stock purchases	0	0	-36,000,000	0	0	0	-69,000,000
cash dividends paid	0	-216,000,000	-216,000,000	-216,000,000	-216,000,000	-413,000,000	-415,000,000	-415,000,000	-415,000,000	-414,000,000	-415,000,000	-408,000,000	-418,000,000	-420,000,000	-413,000,000	-405,000,000	-404,000,000	-403,000,000	-405,000,000	-487,000,000	-403,000,000	-447,000,000	-410,000,000	-399,000,000	-403,000,000	-419,000,000	-422,000,000	-448,000,000	-476,000,000	-402,000,000	-413,000,000	-495,000,000	-411,000,000	-411,000,000	-406,000,000	-387,000,000	-371,000,000	-371,000,000
net cash from financing activities	-812,000,000	-288,000,000	-1,685,000,000	374,000,000	-785,000,000	-313,000,000	186,000,000	-1,460,000,000	-1,193,000,000	2,365,000,000	-599,000,000	-2,252,000,000	-16,000,000	-3,108,000,000	3,877,000,000	-7,180,000,000	-1,209,000,000	-295,000,000	-352,000,000	-1,649,000,000	-913,000,000	-1,219,000,000	-866,000,000	-1,474,000,000	-1,458,000,000	-505,000,000	390,000,000	-3,512,000,000	-1,167,000,000	1,241,000,000	-1,857,000,000	-10,601,000,000	-1,211,000,000	-344,000,000	-778,000,000	-1,035,000,000	-2,537,000,000	-1,207,000,000	-7,143,000,000	9,972,000,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	9,000,000	0	-8,000,000		1,000,000									4,000,000	-20,000,000	-11,000,000	-68,000,000	3,000,000	10,000,000	2,000,000	-2,000,000	-2,000,000	1,000,000	3,000,000			-6,000,000
changes in cash, cash equivalents and restricted cash:
net decrease in cash, cash equivalents and restricted cash	-302,000,000	-68,000,000	-1,910,000,000		25,000,000
cash, cash equivalents and restricted cash at beginning of period	0	0	3,218,000,000		0	0	856,000,000							0	1,270,000,000	0	0	0	746,000,000	0	0	0	1,207,000,000	0	0	0	975,000,000
cash, cash equivalents and restricted cash at end of period	-302,000,000	-68,000,000	1,309,000,000		25,000,000	-131,000,000	846,000,000							-2,241,000,000	4,268,000,000	-533,000,000	492,000,000	-28,000,000	1,339,000,000	-197,000,000	-45,000,000	-12,000,000	1,000,000,000	169,000,000	29,000,000	-174,000,000	1,183,000,000
(earnings) income from equity method investments			10,000,000
impairment of intangibles and long-lived assets			281,000,000				165,000,000
loss on variable prepaid forward contracts			200,000,000		-155,000,000	522,000,000	366,000,000
net earnings								-208,000,000	-48,000,000	544,000,000	-3,816,000,000	-501,000,000	229,000,000	806,000,000	3,531,000,000	613,000,000	1,173,000,000	1,025,000,000	-299,000,000	356,000,000	-1,725,000,000	951,000,000	842,000,000	687,000,000	1,037,000,000	1,138,000,000	1,100,000,000	1,514,000,000	1,346,000,000	1,349,000,000	822,000,000	807,000,000	1,165,000,000	1,062,000,000	1,067,000,000	1,107,000,000	32,000,000	1,310,000,000
adjustments to reconcile net earnings to net cash from operating activities:
gain on previously held investment interests												0	0	0	-2,576,000,000
impairment of equity method investments and investments in equity and debt securities
gain on variable prepaid forward contracts
changes in operating assets and liabilities:
acquisition of non-controlling interests								0	-277,000,000			0	0
proceeds from issuance of non-controlling interests								-10,000,000	212,000,000
proceeds from variable prepaid forwards
early debt extinguishment												-1,133,000,000				0
effect of exchange rate changes on cash, cash equivalents, marketable securities and restricted cash								3,000,000	4,000,000	9,000,000	4,000,000	-14,000,000
changes in cash, cash equivalents, marketable securities and restricted cash
net increase in cash, cash equivalents, marketable securities and restricted cash								-261,000,000	-875,000,000	-2,322,000,000	1,756,000,000	-1,982,000,000
cash, cash equivalents, marketable securities and restricted cash at beginning of period								0	0	0	2,558,000,000	0
cash, cash equivalents, marketable securities and restricted cash at end of period								-261,000,000	-876,000,000	-2,321,000,000	4,314,000,000	-1,983,000,000
wba fiscal 2024 form 10-k
wba q3 2024 form 10-q
wba q2 2024 form 10-q
net increase in cash, cash equivalents and restricted cash							-10,000,000							-2,242,000,000	2,998,000,000		492,000,000	-28,000,000	594,000,000		-45,000,000	-12,000,000	-206,000,000		28,000,000	-174,000,000	208,000,000
loss on early extinguishment of debt												2,000,000				-5,000,000
proceeds from sale of business, net of cash disposed
proceeds from variable prepaid forward								1,924,000,000
proceeds related to employee stock plans								11,000,000	12,000,000	16,000,000	6,000,000	14,000,000	-19,000,000	13,000,000	19,000,000	18,000,000	20,000,000	17,000,000	4,000,000	15,000,000	12,000,000	14,000,000	14,000,000	18,000,000	18,000,000	37,000,000	101,000,000	56,000,000	35,000,000	51,000,000	32,000,000	43,000,000	58,000,000	75,000,000	41,000,000	46,000,000	103,000,000	107,000,000
wba fiscal 2023 form 10-k
impairment of intangible assets
impairment of equity method investments and investments in debt and equity securities												0
stock purchases									0	0	-150,000,000	0	0	-33,000,000	-154,000,000	0	0	0	-110,000,000	-215,000,000	-461,000,000	-440,000,000	-473,000,000	-434,000,000	-613,000,000	-2,201,000,000	-912,000,000	-2,703,000,000	0	0	-2,525,000,000	-3,763,000,000	-1,000,000,000	0	-457,000,000	0	-395,000,000	-237,000,000
changes in cash, cash equivalents, marketable securities and restricted cash:
wba q3 2023 form 10-q
impairment of equity method investments and investments in equity securities
wba q2 2023 form 10-q
goodwill and intangible impairments
gain on sale of business
equity (earnings) income from equity method investments													-133,000,000	-133,000,000	-93,000,000		-676,000,000	-97,000,000	1,350,000,000								-54,000,000				99,000,000
gain on sale of equity method investment																-31,000,000	-99,000,000
net cash (used for) investing activities															-1,958,000,000
equity loss (earnings) from equity method investments
changes in cash, cash equivalents and restricted cash
net increase in cash, cash equivalents, and restricted cash
gain on previously held equity interest																																					143,000,000	0
equity earnings from equity method investments																												-60,000,000	-67,000,000			7,000,000	-63,000,000	-58,000,000	-29,000,000	-18,000,000
goodwill and intangible asset impairment
proceeds from sale leaseback transactions																																8,000,000	0	0	436,000,000	0	0
equity (earnings) from equity method investments																					-250,000,000	-43,000,000	-4,000,000		21,000,000
change in fair value of warrants and related amortization																																				259,000,000	534,000,000	-454,000,000
proceeds from sale of businesses
investment in amerisourcebergen
effect of exchange rate changes on cash and cash equivalents																												-11,000,000	-18,000,000	20,000,000	24,000,000	26,000,000	42,000,000	-3,000,000	-45,000,000	45,000,000	-25,000,000	5,000,000	-89,000,000	-10,000,000
changes in cash and cash equivalents:
net increase in cash and cash equivalents																												-1,033,000,000								-295,000,000	-1,449,000,000	1,444,000,000	-9,603,000,000	9,962,000,000
cash and cash equivalents at beginning of period																												0	0	0	3,301,000,000				9,807,000,000	0	0	0
cash and cash equivalents at end of period																												-1,033,000,000	69,000,000	-81,000,000	1,830,000,000				9,598,000,000	-295,000,000	-1,449,000,000	1,444,000,000	-6,957,000,000	9,962,000,000
business and intangible asset acquisitions, net of cash acquired																													-845,000,000	-3,110,000,000	-265,000,000	-25,000,000
net decrease in cash and cash equivalents																														-81,000,000	-1,471,000,000				-209,000,000
proceeds and payments from short-term borrowings																															1,026,000,000		201,000,000	27,000,000	49,000,000
proceeds from issuance of debt																															110,000,000
alliance boots acquisition, net of cash acquired
proceeds and payments of short-term borrowings
proceeds from issuance of long-term debt																																					6,000,000	0	2,259,000,000	10,020,000,000
payments of long-term debt																																-6,156,000,000	-31,000,000	-5,000,000	-4,000,000	50,000,000	-1,890,000,000	-765,000,000
business and intangible asset acquisitions, net of cash received																																		-37,000,000	-15,000,000
net cash from (used) for investing activities																																			89,000,000
adjustments to reconcile net earnings to net cash from operating activities -
changes in operating assets and liabilities -
proceeds related to sale of business
alliance boots acquisition, net of cash received																																						0
other business and intangible asset acquisitions, net of cash received																																				-29,000,000		-20,000,000
payments of short-term borrowings																																					25,000,000	79,000,000
proceeds from sale of business
purchases of short-term investments held to maturity																																					-8,000,000	-12,000,000
proceeds from short-term investments held to maturity																																					8,000,000	13,000,000
proceeds (payments) of short-term borrowings
loss on exercise of call option
equity earnings in alliance boots																																					0	0
proceeds related to the sale of businesses
other business and intangible asset acquisitions, net of cash acquired
proceeds from financing leases
unrealized gain from fair value adjustments																																						-46,000,000
proceeds related to the sale of business
proceeds from sale of assets
return of restricted cash
payment of debt issuance costs																																								-48,000,000

We provide you with 20 years of cash flow statements for Walgreens Boots Alliance stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Walgreens Boots Alliance stock. Explore the full financial landscape of Walgreens Boots Alliance stock with our expertly curated income statements.

The information provided in this report about Walgreens Boots Alliance stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.